Palisade Bio (PALI) News Today → Forget the “Magnificent 7” Tech Companies, Buy This AI Stock Instead (From Banyan Hill Publishing) (Ad) Free PALI Stock Alerts $6.24 +0.02 (+0.32%) (As of 05/14/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 14 at 5:44 PM | seekingalpha.comPalisade Bio GAAP EPS of -$4.59May 14 at 8:05 AM | globenewswire.comPalisade Bio Reports First Quarter 2024 Financial Results and Provides Business UpdateMay 14 at 12:07 AM | msn.comPALI Stock Earnings: Palisade Bio Beats EPS for Q1 2024May 7, 2024 | globenewswire.comPalisade Bio Appoints Margery Fischbein to its Board of DirectorsMay 7, 2024 | globenewswire.comPalisade Bio Announces Closing of $4 Million Private Placement Priced At-The- Market Under Nasdaq RulesMay 2, 2024 | globenewswire.comPalisade Bio Announces $4 Million Private Placement Priced At-The- Market Under Nasdaq RulesMay 1, 2024 | msn.comMarijuana reclassified federally in major win for the legal cannabis industryMay 1, 2024 | msn.comPalisade Bio stock rallies 50% premarket on colitis drug updateMay 1, 2024 | finance.yahoo.comPalisade Bio’s Lead Product Candidate, PALI-2108 Demonstrates Potent Anti-Inflammatory Effects in Ex-Vivo Study of Whole Blood Samples Challenged with Pro-Inflammatory Lipopolysaccharide (LPS)May 1, 2024 | marketbeat.comTrading was temporarily halted for "PALI" at 09:05 AM with a stated reason of "LULD pause."May 1, 2024 | globenewswire.comPalisade Bio's Lead Product Candidate, PALI-2108 Demonstrates Potent Anti-Inflammatory Effects in Ex-Vivo Study of Whole Blood Samples Challenged with Pro-Inflammatory Lipopolysaccharide (LPS)April 23, 2024 | msn.comPalisade Bio, Strand Life Sciences team up on colitis drug researchApril 23, 2024 | msn.comWhy Palisade Bio Stock Is Up TodayApril 23, 2024 | marketbeat.comTrading was temporarily halted for "PALI" at 09:04 AM with a stated reason of "LULD pause."April 23, 2024 | marketbeat.comTrading was temporarily halted for "PALI" at 09:04 AM with a stated reason of "LULD pause."April 23, 2024 | finance.yahoo.comPalisade Bio Enters into Strategic Collaboration with Strand Life Sciences to Advance Precision Medicine ApproachApril 23, 2024 | globenewswire.comPalisade Bio Enters into Strategic Collaboration with Strand Life Sciences to Advance Precision Medicine ApproachApril 19, 2024 | benzinga.comLooking Into Palisade Bio's Recent Short InterestApril 17, 2024 | markets.businessinsider.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: SAGE Therapeutics (SAGE) and Palisade Bio (PALI)April 17, 2024 | msn.comHow Apple Car Key Works (and Why It Still Hasn’t Caught On)April 16, 2024 | msn.comPalisade Bio stock rallies nearly 100% on colitis drug analysisApril 16, 2024 | marketwatch.comPalisade Bio Shares Surge 80% After Lab Study Results for Ulcerative Colitis TreatmentApril 16, 2024 | msn.comWhy Palisade Bio Stock Is Soaring TodayApril 16, 2024 | investorplace.comWhy Is Palisade Bio (PALI) Stock Up 57% Today?April 16, 2024 | marketbeat.comTrading was temporarily halted for "PALI" at 09:04 AM with a stated reason of "LULD pause."April 16, 2024 | finance.yahoo.comPalisade Bio Successfully Demonstrates Bioactivation of PALI-2108 In Ex-Vivo Study of Normal Healthy and Ulcerative Colitis Patients’ StoolApril 16, 2024 | globenewswire.comPalisade Bio Successfully Demonstrates Bioactivation of PALI-2108 In Ex-Vivo Study of Normal Healthy and Ulcerative Colitis Patients' StoolApril 12, 2024 | uk.investing.comPalisade Bio advances ulcerative colitis treatment to Phase 1 studyApril 11, 2024 | globenewswire.comPalisade Bio to Participate in the Virtual Investor Lunch Break EventApril 10, 2024 | msn.comPalisade Bio stock slides 8% amid colitis drug presentationApril 10, 2024 | finance.yahoo.comPalisade Bio Presents Development Overview of PALI-2108 at the IBD Innovate: Product Development for Crohn’s & Colitis™April 10, 2024 | globenewswire.comPalisade Bio Presents Development Overview of PALI-2108 at the IBD Innovate: Product Development for Crohn's & Colitis™April 8, 2024 | marketbeat.comTrading was temporarily halted for "PALI" at 07:04 PM with a stated reason of "News pending."April 6, 2024 | morningstar.comPalisade Bio Inc 7NSApril 3, 2024 | globenewswire.comPalisade Bio Announces 1-for-15 Reverse Stock SplitMarch 27, 2024 | finance.yahoo.comPalisade Bio Reports Year End 2023 Financial Results and Provides Corporate UpdateMarch 27, 2024 | investorplace.comPALI Stock Earnings: Palisade Bio Beats EPS for Q4 2023February 15, 2024 | finance.yahoo.comPalisade Bio to Present at Digestive Disease Week (DDW) 2024February 15, 2024 | globenewswire.comPalisade Bio to Present at Digestive Disease Week (DDW) 2024February 13, 2024 | finanznachrichten.dePalisade Bio, Inc.: Palisade Bio Provides Corporate Update and Reiterates GuidanceFebruary 13, 2024 | marketwatch.comPalisade Names Donald Williams Chairman, Cuts Board Size in HalfFebruary 13, 2024 | finance.yahoo.comPalisade Bio Provides Corporate Update and Reiterates GuidanceFebruary 8, 2024 | finance.yahoo.comPalisade Bio Announces Formation of Clinical Advisory Board with Appointments of Preeminent Key Opinion LeadersJanuary 31, 2024 | msn.comFTC more `focused' on stopping bad deals after Amazon-iRobot - reportJanuary 30, 2024 | msn.comPalisade Bio Shares Updates and Drug Candidate ProgressJanuary 30, 2024 | finance.yahoo.comPalisade Bio Announces Exercise of Previously Issued Warrants for $2.5 MillionJanuary 30, 2024 | marketwatch.comPalisade Bio Shares Drop 23% After Warrants ExercisedJanuary 30, 2024 | finance.yahoo.comPalisade Bio Announces Exercise of Previously Issued Warrants for $2.5 MillionJanuary 29, 2024 | investorplace.comWhy Is Palisade Bio (PALI) Stock Up 100% Today?January 29, 2024 | finanznachrichten.dePalisade Bio, Inc.: Palisade Bio Announces Positive Preclinical Data of Lead Program PALI-2108 at the 2024 Crohn's & Colitis Congress Get Palisade Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for PALI and its competitors with MarketBeat's FREE daily newsletter. Email Address America’s worst nightmare? (Ad)What This Group Has Planned for the 2024 Election Will Shock You Controversial new exposé reveals what’s really going on in America, what it means for your money, and what you must do to protect your assets before it’s too late. Click here to watch this bombshell exposé now. PALI Media Mentions By Week PALI Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PALI News Sentiment▼0.280.56▲Average Medical News Sentiment PALI News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PALI Articles This Week▼62▲PALI Articles Average Week Get Palisade Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for PALI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: CELZ News TTNP News FRTX News IKT News SRNE News PSTV News ONVO News TCON News FNCH News KRBP News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PALI) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldForget the “Magnificent 7” Tech Companies, Buy This AI Stock InsteadBanyan Hill PublishingWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsGold Set to EXPLODE!Gold Safe ExchangeThe Crypto 9-5 Escape PlanCrypto 101 MediaThe A.I. story nobody is telling you (Read ASAP)TradeSmithBuy this small stock before coming AI Tidal WaveChaikin AnalyticsElon’s New Device is About to Shock the WorldInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Palisade Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
